SAMANTHA JENSEN: Open Payments
NPI 1083487920 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 42 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,471 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $221 |
| Lilly USA, LLC | 5 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| Janssen Biotech, Inc. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| Celltrion USA Inc. | 3 | $56 |
| GENZYME CORPORATION | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Ardelyx, Inc. | 1 | $21 |
Products named: ENTYVIO, DUPIXENT, RINVOQ, OMVOH, SKYRIZI, TREMFYA, VOQUEZNA, VEGZELMA.
Industry payments across IA — which companies pay providers there.
